Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525518) titled 'Okami Medical ALPHA Registry' on April 6.

Study Type: Observational [Patient Registry]

Primary Sponsor: Okami Medical, Inc.

Condition: Arterial Bleed Pulmonary Arteriovenous Malformation Embolization Hemorrhage

Intervention: Device: LOBO Vascular Occlusion System

Recruitment Status: Recruiting

Date of First Enrollment: March 31, 2026

Target Sample Size: 500

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07525518

Published by HT Digital Content Services with permission from Health Daily Digest....